Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 Kinase
Schulze, Volker K, Klar, Ulrich, Kosemund, Dirk, Wengner, Antje M, Siemeister, Gerhard, Stöckigt, Detlef, Neuhaus, Roland, Lienau, Philip, Bader, Benjamin, Prechtl, Stefan, Holton, Simon J, Briem, Hans, Marquardt, Tobias, Schirok, Hartmut, Jautelat, Rolf, Bohlmann, Rolf, Nguyen, Duy, Fernández-Montalván, Amaury E, Bömer, Ulf, Eberspaecher, Uwe, Brüning, Michael, Döhr, Olaf, Raschke, Marian, Kreft, Bertolt, Mumberg, Dominik, Ziegelbauer, Karl, Brands, Michael, von Nussbaum, Franz, Koppitz, Marcus
Published in Journal of medicinal chemistry (13.08.2020)
Published in Journal of medicinal chemistry (13.08.2020)
Get full text
Journal Article
Abstract 2645: BAY 1436032: A highly selective, potent and orally available inhibitor of mutant forms of IDH1
Panknin, Olaf, Pusch, Stefan, Herbst, Lena, Kaulfuss, Stefan, Zimmermann, Katja, Rehwinkel, Hartmut, Neuhaus, Roland, Ring, Sven, Brüning, Michael, Stark, Claudia, Prelle, Katja, Michels, Martin, Jeffers, Michael, Hess-Stumpp, Holger, Ziegelbauer, Karl, Brands, Michael, Krämer, Alwin, von Deimling, Andreas
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
SUBSTITUTED IMIDAZOPYRIDAZINES
KLAR Ulrich, BRUNING Michael, WENGNER Antje Margret, KOPPITZ Marcus, SIEMEISTER Gerhard, NEUHAUS Roland
Year of Publication 31.01.2018
Get full text
Year of Publication 31.01.2018
Patent